Wanzhong Yixin
万众一芯
Wanzhong Yixin (万众一芯) is an innovative biomedical company backed by Qiming Venture Partners — in July 2025 it joined the newly launched Chengdu Regional Clinical Research Alliance as a member, identified as "an innovative biotech/biomedical enterprise" . It also appeared on the BEYOND Awards MedTech Transcendence list alongside fellow Qiming portfolio companies in mid-2025 , and on VBData's 2026 Future Healthcare 100 .
Beyond these award and alliance appearances, elsewhere's corpus has no substantive coverage of Wanzhong Yixin's founding, products, or financing history.
AI-generated — may contain errors, please verify.
Coverage
Qiming Venture Partners and Nearly 40 Portfolio Companies Named to VBData 2026 Future Healthcare 100
China's most authoritative and influential innovation benchmark for the healthcare industry
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 24, 2025
Following Qiming Venture Partners' portfolio companies and their milestone moments with you
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 20, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Morning Star | Five Qiming Venture Partners Portfolio Companies Named to BEYOND Awards MedTech Transcendence and Health Leadership Lists
The BEYOND Awards Medical Technology Transcendence List seeks to identify and honor the transcendent forces in medical technology that demonstrate exceptional innovation capabilities and achieve "defining industry top standards"; the Great Health Navigation List focuses on leading enterprises that truly meet consumer health needs and exhibit strong growth potential and outstanding innovation capabilities.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 16, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
